Skip to content

Effects of transcranial direct current stimulation (tDCS) plus physical therapy on gait in Parkinson

Effects of transcranial direct current stimulation (tDCS) plus physical therapy on gait in Parkinson

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160330002
Enrollment
Unknown
Registered
2016-03-30
Start date
2011-05-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

The 1st group was treated with anodal tDCS 2 mA stimulated on lower extremity motor cortex for 30 minutes.,The 2nd group was treated with the same anodal tDCS protocol and underwent physical therapy
Active Comparator Procedure/Surgery,Experimental Procedure/Surgery,Sham Comparator Procedure/Surgery
First group,Second group,Third group

Sponsors

Ratchadapiseksompotch Fund
Lead Sponsor
Ratchadapiseksompotch Fund
Collaborator

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 40 to 80 year-old 2. Patients who were diagnosed with Parkinson disease under the diagnosis criterion of United Kingdom Parkinson’s Disease Society Brain Bank Diagnostic Criteria for Parkinson’s Disease. 3. Patients who are at stage 2 & 3 of Parkinson’s disease, which certified by modified Hoehn & Yahr Staging criterion. 4. Patients who has been treated with medication regularly with no changes in medication during the study period. 5. Patients who have slower walking speed than normal elderly were enrolled (average walking speed was set at 0.4 to 0.9 meters per second) 6. Patients who agreed to participated throughout the whole period settled

Exclusion criteria

Exclusion criteria: 1. Patients who were unable to walk (on a flat surface) by themselves or needed to use gait aid 2. Patients who previously had epilepsy or had done a surgery in around the skull area (might be dangerous or risky to do tDCS). 3. Patients who have been taking sodium channel blocker or calcium channel blocker medicine. 4. Patients who have other abnormalities that affect the motor system and communication skills such as dementia, stroke, patients with bone disease or eye diseases that affect their visual ability.

Design outcomes

Primary

MeasureTime frame
gait parameters 2, 4, 8 week post treatment gait and motion analysis

Secondary

MeasureTime frame
none none none

Countries

Thailand

Contacts

Public ContactKrisna Piravej

Faculty of Medicine

kppmrchula@gmail.com022564433

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026